DATA SHEET
IBM Explorys Electronic
Highlights:
– A rich, integrated, and growing living
clinical data set that is HIPAA-
enabled, including more than 63
million unique patients
– A comprehensive picture of the
patient experience is provided with
data sourcing from integrated
delivery networks (IDNs), clinically
integrated networks (CINs), and
accountable care organizations
(ACOs), closing the data gaps that
plague other electronic medical
record (EMR)-based data sets
– Extensive data curation, quality
assurance, and quality control to
strengthen data quality, accuracy,
and harmonization
– Unique capabilities, including near
real-time analyses, supported by
strong relationships with an
expanding group of providers
– Turnkey functionality and advanced
data management through seamless
partnering with IBM's analytic tools
and consulting services
– Cloud-based, security-rich platform
for ease-of-access and flexibility
Health Record (EHR)
Database
Confidently and efficiently generate
the data-driven insights that you
need to make business-critical
decisions
How Users May Benefit
For life sciences organizations that require clinical
insights, IBM® Explorys® offerings are real-world,
near real-time, cloud-based clinical data assets
and analytic solutions. They help industry
professionals confidently and efficiently generate
data-driven insights needed to make business-
critical decisions across a range of functional areas
including medical affairs, clinical development,
health economics and outcomes research,
epidemiology, and commercialization.
Rich Data > Deep Insights > Confident Decisions
Built upon clinical data, captured with breadth,
depth, and completeness, the IBM Explorys
offerings for life sciences tap a wealth of clinical
information for more than 63 million unique
patients. Deep, longitudinal data is available for
these patients for an average of 3-4 years. The data
also spans the continuum of care, from ambulatory
to inpatient to specialty care. IDN, CIN, and ACO
data sourcing provides a comprehensive picture of
the patient experience, closing the gaps that
plague other EMR-based data sets. An extensive
curation process helps improve accuracy and
facilitates analysis by transforming disparate date
and mapping key elements to widely-accepted
standards. This living data set uses a data
collection system that combines data streamed
from a diverse and growing array of large,
integrated health delivery systems and
community-based networks. As a result, it can
uniquely enable near real-time analyses, data
enrichment, and innovative, customized offerings.
How the IBM Explorys Offerings for Life
Sciences Can Help Your Organization
- Understand the complete patient
experience, including treatment adherence
- Explore market dynamics and test business
assumptions
- Support outcomes and quality-of-life
modeling
- Conduct analyses that facilitate outcome-
based contracting
- Focus research and development (R&D)
efforts, optimize clinical trial protocols and
enhance clinical trial enrollment and
management
- Monitor product launches in near real-time
and conduct post-marketing surveillance
- Assess impacts of regulatory and
competitive changes
Efficient Generation of Real-World Data for Health Informatics
A Wealth of Clinical Information
in a Living Data Set
- Streams partner IDN, CIN, and ACO data
direction from a multitude of data sources,
including clinical EMRs, community practice
management systems, billing, adjudicated payer
claims, HL7, enterprise data warehouse (EDW),
and health information exchange (HIE) feeds.
- Provides readily available clinical information not
typically found in other data sets, including
provider interactions and behavior, deep
laboratory results (including microbiology), vitals
and biometrics, patient-reported outcomes, and
implantable device details.
- Provides particularly rich data in major chronic
disease areas, including cardiology, diabetes,
immunology, infectious disease, and neurology.
- Constantly refines data to meet evolving client
needs, with the ability to obtain additional data
elements through direct connections to provider
partners. Examples include microbiology data,
implantable device data, and oncology
information.
The Smart Choice for Your Clinical Insight Needs

The IBM Explorys offerings for life sciences provide turnkey functionality and advanced data
management capabilities through seamless partnering with IBM's first-class analytics, software, and
consulting services, with the future addition of cognitive computing. The solutions offer flexible tools
that can be scaled to meet specific and organization-wide objectives. As part of the IBM Watson
Health digital ecosystem, the IBM Explorys offerings for life sciences are strongly supported by IBM's
unparalleled experience, track record, and research and innovation. The goal is to provide the fully
integrated information management solutions needed to succeed in today's rapidly changing
healthcare environment.

IBM Explorys Data and Associated Tools

For More Information

To learn more about IBM Explorys EHR Database offerings for Life Sciences, please contact your
IBM representative or visit the followig website: http://www.ibm.com/watson/health/explorys/
healthcare-analytics/
The information in this document is provided “as is” without any warranty,
express or implied, including without any warranties of merchantability,
IBM Corporation © Copyright IBM Corporation 2017, 2019
fitness for a particular purpose and any warranty or condition of non-
Software Group
infringement.
Route 100

Somers, NY 10589
Produced in the United States of America, May 2019
IBM, the IBM logo, ibm.com, and Watson Health are trademarks of International
Business Machines Corp., registered in many jurisdictions worldwide. Other product
and service names might be trademarks of IBM or other companies.
A current list of IBM trademarks is available on the Web at “Copyright and trademark
information” at:
ibm.com/legal/copytrade.shtml
This document is current as of the initial date of publication and may
be changed by IBM at any time. This document is current as of the initial date of
publication and may be changed by IBM at any time. Not all offerings are available in
every country in which IBM operates.
IBM products are warranted according to the terms and conditions of the
agreements under which they are provided.
Statement of Good Security Practices: IT system security involves protecting
systems and information through prevention, detection and response
to improper access from within and outside your enterprise. Improper access
can result in information being altered, destroyed or misappropriated or can
result in damage to or misuse of your systems, including to attack others.
No IT system or product should be considered completely secure and no
single product or security measure can be completely effective in preventing
improper access. IBM systems and products are designed to be
part of a comprehensive security approach, which will necessarily
involve additional operational procedures, and may require other systems,
products or services to be most effective. IBM does not warrant that systems
and products are immune from the malicious or illegal conduct of any party.